Species differences in peroxisome proliferation; mechanisms and relevance

被引:40
作者
Choudhury, AI
Chahal, S
Bell, AR
Tomlinson, SR
Roberts, RA
Salter, AM
Bell, DR
机构
[1] Univ Nottingham, Sch Biol Sci, Nottingham NG7 2RD, England
[2] Astra Charnwood Safety Assessment, Loughborough LE11 5RH, Leics, England
[3] Zeneca Cent Toxicol Lab, Macclesfield SK10 4TJ, Cheshire, England
基金
英国惠康基金;
关键词
peroxisome proliferation-activated receptor alpha (PPAR alpha); pleiotropic response; peroxisome proliferators;
D O I
10.1016/S0027-5107(99)00237-7
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Peroxisome proliferators are a class of structurally diverse chemicals, which induce liver carcinogenesis in rodents through interaction and activation of the Peroxisome Proliferator-Activated Receptor alpha (PPAR alpha). PPAR alpha agonists elicit a powerful pleiotropic response, which include hypolipidaemia. We have examined the response of species that are classically unresponsive to peroxisome proliferators. Whereas hamster responds to PPAR alpha agonists by hepatomegaly and induction of marker genes, the guinea pig does not undergo hepatomegaly or induction of marker genes, such as CYP4A13. Both the hamster and the guinea pig have PPAR alpha, and the guinea pig receptor has been characterised to be fully functional. as demonstrated in reporter gene expression assays. However, the guinea pig PPAR alpha is expressed at low levels in liver, and the currently favoured hypothesis to explain species differences in hepatic peroxisome proliferation invokes the low level of PPAR alpha as the principal determinant of species responsiveness. However, the demonstration that guinea pigs and humans undergo hypolipidaemia induced by PPAR alpha-agonists calls into question the mode of action of PPAR alpha agonists in "non-responsive" species. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:201 / 212
页数:12
相关论文
共 78 条
[41]   PEROXISOME PROLIFERATOR-BINDING PROTEIN - IDENTIFICATION AND PARTIAL CHARACTERIZATION OF NAFENOPIN-BINDING, CLOFIBRIC ACID-BINDING, AND CIPROFIBRATE-BINDING PROTEINS FROM RAT-LIVER [J].
LALWANI, ND ;
ALVARES, K ;
REDDY, MK ;
REDDY, MN ;
PARIKH, I ;
REDDY, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (15) :5242-5246
[42]  
LEE SST, 1995, MOL CELL BIOL, V15, P3012
[43]   SPECIES-DIFFERENCES IN CIPROFIBRATE INDUCTION OF HEPATIC CYTOCHROME P450 4A1 AND PEROXISOME PROLIFERATION [J].
MAKOWSKA, JM ;
GIBSON, GG ;
BONNER, FW .
JOURNAL OF BIOCHEMICAL TOXICOLOGY, 1992, 7 (03) :183-191
[44]   COMPARATIVE INDUCTION OF CYTOCHROME-P450IVA1 AND PEROXISOME PROLIFERATION BY CIPROFIBRATE IN THE RAT AND MARMOSET [J].
MAKOWSKA, JM ;
BONNER, FW ;
GIBSON, GG .
ARCHIVES OF TOXICOLOGY, 1991, 65 (02) :106-113
[45]  
Maniatis T., 1982, MOL CLONING A LAB MA
[46]  
MARSMAN DS, 1988, CANCER RES, V48, P6739
[47]   LACK OF EVIDENCE FOR A HEPATIC PEROXISOME PROLIFERATOR RECEPTOR AND AN EXPLANATION FOR THE BINDING OF HYPOLIPEMIC DRUGS TO LIVER HOMOGENATES [J].
MILTON, MN ;
ELCOMBE, CR ;
KASS, GEN ;
GIBSON, GG .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (05) :793-798
[48]   SPECIES-DIFFERENCE IN HEPATIC PEROXISOME PROLIFERATION [J].
MITCHELL, AM ;
JOSEPH, K ;
ELCOMBE, CR .
HUMAN TOXICOLOGY, 1985, 4 (05) :552-552
[49]   IDENTIFICATION OF THE PROXIMATE PEROXISOME PROLIFERATOR(S) DERIVED FROM DI(2-ETHYLHEXYL) PHTHALATE [J].
MITCHELL, AM ;
LHUGUENOT, JC ;
BRIDGES, JW ;
ELCOMBE, CR .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1985, 80 (01) :23-32
[50]  
Mohan WS, 1998, J LIPID RES, V39, P255